Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | WNT5A |
| Upstream (Parents) |
|---|
| (<<) ASNS → WNT5A |
| (<<) ATP2C1 → WNT5A |
| (<<) CDCP1 → WNT5A |
| (<<) CDKN1A → WNT5A |
| (<<) CEBPB → WNT5A |
| (<<) CHSY1 → WNT5A |
| (<<) COL13A1 → WNT5A |
| (<<) CREB3L1 → WNT5A |
| (<<) CXCR7 → WNT5A |
| (<<) DDIT3 → WNT5A |
| (<<) DMPK → WNT5A |
| (<<) DUSP10 → WNT5A |
| (<<) EBP → WNT5A |
| (<<) ENTPD7 → WNT5A |
| (<<) GLI3 → WNT5A |
| (<<) HDAC6 → WNT5A |
| (<<) HEY1 → WNT5A |
| (<<) HIF1A → WNT5A |
| (<<) ICAM1 → WNT5A |
| (<<) IL1B → WNT5A |
| (<<) ITGAV → WNT5A |
| (<<) KCNJ5 → WNT5A |
| (<<) KLHL7 → WNT5A |
| (<<) KYNU → WNT5A |
| (<<) LOC92659 → WNT5A |
| (<<) MMP12 → WNT5A |
| (<<) NFAT5 → WNT5A |
| (<<) NRG1 → WNT5A |
| (<<) POU3F3 → WNT5A |
| (<<) PYGL → WNT5A |
| (<<) ROR2 → WNT5A |
| (<<) SOCS3 → WNT5A |
| (<<) STAT5B → WNT5A |
| (<<) SULF1 → WNT5A |
| (<<) TMEM158 → WNT5A |
| (<<) TMEM87B → WNT5A |
| (<<) TNC → WNT5A |
| Downstream (Children) |
|---|
| WNT5A → CSTA (>>) |
| WNT5A → GPNMB (>>) |
| WNT5A → IGFBP3 (>>) |
| WNT5A → ITGB6 (>>) |
| WNT5A → MKNK1 (>>) |
| WNT5A → PFKFB3 (>>) |
